BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 3, 2021
View Archived Issues
First patient dosed in phase II study of ZN-c3 in uterine serous carcinoma
Read More
Vaxart's IND application for S-only oral tablet COVID-19 vaccine cleared in U.S.
Read More
Hovione Scientia describes ligand drug conjugates including BET inhibitors
Read More
Bristol Myers Squibb patents CD80/PD-L1 and/or PD-1/PD-L1 interaction inhibitors
Read More
New CDK and TRK inhibitors identified at Hangzhou Innogate Pharma
Read More
Ascentage Pharma discovers mutant GTPase KRAS inhibitors
Read More
FDA clears IND for phase I/II MARINA study of AOC-1001
Read More
Dosing begins in phase I study of mRNA-6231
Read More
Prometheus initiates phase IIa APOLLO-CD study of PRA-023 in Crohn's disease
Read More
Discovery of SR-42667: a tau-SH3 interaction inhibitor that prevents Abeta toxicity
Read More
Phase II data show safety and efficacy of OCS-02 in dry eye disease
Read More
Gem gene sparkles as ischemic stroke drug discovery target
Read More
China's NMPA approves INDs for IASO's CD19/CD22 CAR-T therapy
Read More
Collagenase clostridium histolyticum improves foot function in plantar fibromatosis study
Read More
Abcentra studies orticumab in subjects with psoriasis and cardiometabolic risk factors
Read More
Intranasal vaccination with ChAdOx1 nCoV-19 reduces viral shedding in preclinical models
Read More
ST-067 enters first-in-human study in relapsed or refractory solid tumors
Read More
Phase I trial evaluates iPSC-derived CAR T-cell therapy FT-819 for CD19+ malignancies
Read More
Phase I data with ANG-3070 pave way for phase II study in primary proteinuric kidney diseases
Read More
CTA approved in Vietnam for phase I/II/III study of SARS-CoV-2 vaccine ARCT-154
Read More
Dosing underway in phase I/II study of KRAS G12C inhibitor JAB-21822
Read More
Annovis reports interim phase II data on Posiphen in Alzheimer's and Parkinson's disease
Read More
ACD-856 shows preclinical effects on cognition, enters phase I study
Read More
FDA authorizes IND for phase I testing of Sorrento's CD38 DAR-T cell therapy candidate
Read More
Luye Pharma files IND in U.S. to study next-generation VMAT2 inhibitor LY-03015
Read More
